Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2016 Aug;101(8):e352-4.
doi: 10.3324/haematol.2015.140509. Epub 2016 Apr 14.

Unmanipulated haploidentical versus matched unrelated donor allogeneic stem cell transplantation in adult patients with acute myelogenous leukemia in first remission: a retrospective pair-matched comparative study of the Beijing approach with the EBMT database

Yuqian Sun  1 , Eric Beohou  2 , Myriam Labopin  3 , Liisa Volin  4 , Noel Milpied  5 , Ibrahim Yakoub-Agha  6 , Simona Piemontese  7 , Emmanuelle Polge  2 , Mohamed Houhou  2 , Xiao-Jun Huang  8 , Mohamad Mohty  9 , Arnon Nagler  10 , Norbert-Claude Gorin  11 ; Acute Leukemia Working Party of the EBMT
Affiliations
Comparative Study

Unmanipulated haploidentical versus matched unrelated donor allogeneic stem cell transplantation in adult patients with acute myelogenous leukemia in first remission: a retrospective pair-matched comparative study of the Beijing approach with the EBMT database

Yuqian Sun et al. Haematologica. 2016 Aug.
No abstract available

Keywords: T-cell repletion; acute myeloid leukemia; adult; haploidentical donor; matched unrelated donor.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Comparisons of outcome between HID group and URD group (adjusted). OS: Overall survival; LFS: leukemia-free survival.
See this image and copyright information in PMC

References

    1. Kekre N, Antin JH. Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist. Blood. 2014;124(3):334–343. - PubMed
    1. Gragert L, Eapen M, Williams E, et al. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. N Engl J Med. 2014;371(4):339–348. - PMC - PubMed
    1. Aversa F, Martelli MF, Velardi A. Haploidentical hematopoietic stem cell transplantation with a megadose T-cell-depleted graft: harnessing natural and adaptive immunity. Semin Oncol. 2012;39(6):643–652. - PubMed
    1. Luznik L, Bolaños-Meade J, Zahurak M, et al. High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease. Blood. 2010;115(16):3224–3230. - PMC - PubMed
    1. Wang Y, Liu QF, Xu LP, et al. Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study. Blood. 2015;125(25):3956–3962. - PubMed

MeSH terms